FinCEN Flags $17.5B in Health‑Care Fraud Suspected
FinCEN has identified about $17.5 billion in potentially suspicious health‑care fraud activity, signaling a sharp uptick in enforcement focus toward the medical‑service sector.
FinCEN announced on September 9 that it has identified roughly $17.5 billion in suspicious financial activity that “potentially” involves health‑care fraud. The Treasury’s enforcement action signals that the regulator is expanding its focus beyond traditional money‑laundering cases to high‑profile fraudulent schemes in the medical‑service sector. Firms advising health‑care providers, insurers and pharmaceutical companies must review their AML policies, transaction‑monitoring systems, and reporting obligations to ensure compliance with FinCEN’s guidelines. The announcement also highlights the importance of robust due‑diligence on billing partners, pay‑or‑return arrangements, and third‑party intermediaries. While the exact entities targeted remain undisclosed, the magnitude of the suspected fraud underscores the potential scope of liability and the risk of self‑reporting penalties. Clients should assess whether their current controls are aligned with FinCEN’s evolving enforcement priorities and consider independent audits or enhanced training. Monitoring further FinCEN guidance or enforcement actions will be critical as the regulator appears to be tightening scrutiny of health‑care‑related financial flows.